Clinical Trials Logo

Skin Cancer Face clinical trials

View clinical trials related to Skin Cancer Face.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06207786 Not yet recruiting - Skin Cancer Clinical Trials

Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery

Start date: May 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to compare surgical site infection rates for patients treated with Mohs micrographic surgery after bilateral nasal swab with povidone iodine versus standard treatment including the use of a standardized oral antibiotic prophylaxis protocol.

NCT ID: NCT06057675 Not yet recruiting - Skin Cancer Face Clinical Trials

Tranexamic Acid in Nasal Mohs Reconstruction

Start date: April 2024
Phase: Phase 2
Study type: Interventional

This study will be a prospective randomized control trial to evaluate the effects of subcutaneously administered TXA among patients undergoing nasal Mohs reconstruction with local flaps at VUMC.

NCT ID: NCT03382704 Not yet recruiting - Skin Cancer Face Clinical Trials

Lanugo Hair Loss as a Marker for Peri-ocular Malignancy

Start date: April 2018
Phase: N/A
Study type: Observational

Skin cancers around the eye are common, but so are other lid lumps. It is useful to be able to tell which lumps are likely to be cancer. This study looks at whether the loss of fine hairs (lanugo hairs) on the skin are a good indicator of whether a lump is a skin cancer or not. The investigators are recruiting patients who have lid lumps who haven't had a biopsy before, who would be having a biopsy as part of their treatment, and seeing whether those who have loss of the fine skin hairs are the same as those who have skin cancer confirmed on their biopsy. The study doesn't involve any extra examinations or treatments for participants. The investigators look at the patients before the biopsy as part of their usual care, and take a note of whether or not they have lost the fine hairs at this stage. The main benefit of participating is that the medical community has better evidence about which lid lumps are likely to represent skin cancer, helping future diagnosis. There are no additional risks to participating. The risks of biopsy are unchanged whether patients participate in the study or not. The study is run from the Princess Alexandra Eye Pavilion in Edinburgh, in conjunction with Moorfields Eye Hospital, London The investigators aim to start the study in Spring 2018, and will most likely recruit for 6 months depending on the number of participants recruited. There is no additional funding from any source at present - the work will be undertaken by doctors in their research time.